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Abstract
Background:  Epidemiological studies on the potential role of surgery in Creutzfeldt-Jakob
Disease transmission have disclosed associations with history of specific surgical interventions or
reported negative results.
Methods: Within the context of a case-control study designed to address surgical risk of sporadic
Creutzfeldt-Jakob Disease in Nordic European countries (EUROSURGYCJD Project), a strategy
was adopted to categorise reported surgical procedures in terms of potential risk of Creutzfeldt-
Jakob Disease acquisition. We took into account elements of biological plausibility, either clinically
or experimentally demonstrated, such as tissue infectivity, PrP expression content or successful
route of infection.
Results: We propose a classification of exposed tissues and anatomic structures, drawn up on the
basis of their specific putative role as entry site for prion transmission through contact with surgical
instruments that are not fully decontaminated.
Conclusions:  This classification can serve as a reference, both in our study and in further
epidemiological research, for categorisation of surgical procedures in terms of risk level of
Creutzfeldt-Jakob Disease acquisition.
Background
Case-control research on the association between surgery
and sporadic Creutzfeldt-Jakob Disease (CJD) encom-
passes six studies and one meta-analysis [1-8], which fre-
quently yielded diverging, partly inconsistent, positive
[5,6] or negative [7,8] results, potentially attributable to
methodological difficulties. This paper constitutes the
first part of methods development for a case-control study
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summarily described in the Methods/Design section.
"Development" in this sense refers to theoretical develop-
ment built on scientific evidence and will focus on classi-
fication of surgical procedures, using technical and
biological criteria appropriate for identifying characteris-
tics of the intervention reflecting the putative risk level of
sporadic CJD transmission.
Methods
In this section, we summarily describe the on-going study,
review reports that possibly shed light on the biological
plausibility of surgery-related CJD transmission, and pro-
pose principles for re-classification of surgical procedures.
Study design
The on-going case-control study, entitled "Surgery and
risk of Creutzfeldt-Jakob Disease" (EUROSURGYCJD),
constitutes a Concerted Action funded by the EU Research
Commission, contract QLG3-CT-2002-81223. The main
objective of this study is to quantify a putative excess risk
of CJD associated with surgery. A secondary objective is to
establish a basis for the design of preventive strategies. The
most relevant methodological characteristics are: case-
control design; exposure measurement prior to disease
onset, registered as codes for surgical procedures; matched
5:1, randomly chosen population controls and random
sample of population controls. The population base is the
resident population in Denmark, Finland and Sweden,
covered by the respective hospital in-patient registers.
Cases are individuals with diagnoses corresponding to
ICD-9 codes 046.1 and 331.5 and ICD-10 code A81.0 at
death or at hospital discharge for the period 1987–2002,
identified from the respective national hospital in-patient
registers and corresponding national surveillance units. A
questionnaire will be mailed to the heads of the registered
hospital department or surveillance unit, and a copy of
the medical record will be obtained for diagnosis valida-
tion. Approximately 300 patients will fulfil criteria for def-
inite or probable sporadic CJD, and constitute the study
cases. Population controls are: 1) 5 × 1 controls (approxi-
mately 1500), matched to the corresponding case by age,
sex, county of residence of the case (at first discharge from
hospital with CJD diagnosis or death if never hospitalised
with CJD diagnosis); and 2) a 20/million sample of the
1987–2002 resident population aged >40 years, ran-
domly selected from the corresponding national popula-
tion registers.
Individual person-numbers will be used for each resident
case or control. Diagnoses and surgical procedures at hos-
pital discharge of the corresponding CJD case at any regis-
tered time before date of death will be obtained from the
three national hospital discharge registers in Sweden,
Denmark and Finland. Perusal of surgical records might
be undertaken for selected associations in order to under-
stand transmission mechanisms and interpret results.
Open-care surgery or dentistry will not be studied. Surgi-
cal procedures coded in registers as per national or
NOMESCO classifications will be re-classified in accord-
ance with putative levels of transmission risk based on sci-
entific evidence/plausibility.
The quality of CJD diagnoses will be assessed by a review
of medical records. The accuracy of surgical history given
by the registers will be assessed by comparison with that
of a sample of controls and surrogate respondents
obtained by interview.
Centralised data analyses will be conducted by the Span-
ish team. In specific instances, risk due to blood transfu-
sion, whether or not performed during surgical
procedures, might also be studied.
Review of reports and proposal
Surgery may be a pathway for patient-to-patient transmis-
sion of sporadic Creutzfeldt-Jakob Disease (CJD). In
many invasive surgical procedures, non-disposable surgi-
cal instruments come in contact with tissues that are
known to be infective in CJD patients. These same instru-
ments may retain a considerable level of infectivity after
routine sterilisation, and in successive patients can come
into contact with tissues that may act as entry sites for CJD
transmission. Among the almost 300 recorded cases of
iatrogenic transmission of CJD, 5 cases have been attrib-
uted to surgical instruments employed in neurosurgical
procedures, whilst 2 additional cases were caused by the
use of a contaminated intracerebral EEG electrode [9]. To
date, proven surgical transmission of CJD has only been
shown to have taken place through instruments contami-
nated with high-infectivity tissues (brain). However,
stainless steel instruments exposed to infective tissue can
acquire a maximum load of infectivity in a considerably
short period of time (5 minutes) and are highly efficient
in transmitting disease even after thorough washing [10].
The possibility of prion transmission through surgical
interventions involving nervous or peripheral tissue has
raised concern about decontaminating procedures, partic-
ularly after the emergence of variant CJD in the United
Kingdom and several other countries [11].
In the above-mentioned studies [1-7], surgical procedures
have been grouped and analysed according to gross ana-
tomical regions (e.g., thyroid, gallbladder, prostate, etc.),
which limits an interpretation of results based on biolog-
ical inference. For a surgical instrument to act as a vehicle
of prion transmission, it should come into contact with
infective tissue during surgery of the "donor" (contami-
nating procedure), should maintain any adhered infectiv-
ity after being washed and sterilised, and, finally, should
make contact with receptive tissues in the "recipient"BMC Public Health 2005, 5:9 http://www.biomedcentral.com/1471-2458/5/9
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patient (transmitting procedure). Different surgical inter-
ventions on the same organ may result in direct exposure
of different tissues to surgical instruments, and may con-
sequently involve a different risk of prion transmission.
Within the context of a case-control study designed to
address surgical risk in sporadic CJD in Nordic European
countries (EUROSURGYCJD Project), we adopted the
strategy of categorising all reported surgical procedures
(putative transmitting procedures) in terms of potential
risk of CJD acquisition. For this purpose, a classification
of exposed tissues and anatomic structures has been
drawn up on the basis of their specific putative role as
entry site for prion transmission through surgical instru-
ments. This classification can serve, both in our study and
in further epidemiological studies, as a reference for a cat-
egorisation of surgical procedures in terms of risk of CJD
acquisition.
According to the "protein only" hypothesis [12], patho-
genic prion protein (PrPSc) is a conformational isoform of
PrPC, a normal host protein present in neurons and other
cell types. In sporadic and familial transmissible spongi-
form encephalopathies (TSEs), "spontaneous" conversion
of PrPC into PrPSc is the key pathogenic event, followed by
the accumulation, deposition and further conversion of
PrPSc in tissues, together with its propagation along spe-
cific neural pathways. In the case of transmitted TSEs -
when these are not due to direct inoculation into the CNS-
a peripheral phase of neuroinvasion by PrPSc is followed
by a subsequent phase of prion replication and propaga-
tion along the peripheral nervous system, with final access
to the central nervous system [13]. In scrapie, bovine
spongiform encephalopathy (BSE) and variant CJD, neu-
roinvasion follows widespread deposition of PrPSc  in
mucosae-associated lymphoid tissue. For the purpose of
classifying tissues susceptible to prion inoculation, the
following considerations can be derived from this patho-
genic model: i) a tissue can act as entry site for prion trans-
mission if it normally expresses PrPC; ii) the level of PrPSc
expression of an infected tissue correlates positively with
the risk of prion acquisition by that tissue; and, iii) all tis-
sues involved in the propagation chain of infection from
peripheral tissues to the central nervous system can act as
entry sites for prion transmission.
The recently published WHO classification of tissue infec-
tivity in TSEs [14], though aimed at public health issues
radically different from those addressed in our study, may
nonetheless serve as a conceptual framework for a tissue
classification in terms of risk level of prion acquisition.
This approach is based on our above-mentioned assump-
tion (ii). The WHO classification groups tissues in three
levels (high, lower and no detected infectivity) on the
basis of bioassay infectivity data and/or detection of PrPSc
by Western blot. This three-level classification correlates
quite closely with the distribution and levels of PrPC
expression in normal nervous and non-nervous tissues in
mammals.[15] The WHO tissue classification presents
data on vCJD, other human TSEs, BSE and scrapie. Since
no vCJD cases have been registered in Nordic countries,
our epidemiological study must be limited to sporadic
CJD. Consequently, our working classification excludes
all tissues where positive data on infectivity or PrPSc detec-
tion have been obtained exclusively in animal TSEs and/
or vCJD. This is the case of the small bowel, large bowel
(including enteric nerve plexuses), adrenal tissue, pan-
creas and bone marrow.
Further relevant data for tissue classification derive from
iatrogenic CJD cases and from experimental transmission
of prion diseases to animals. In roughly half of iCJD cases
the entry site has been the CNS or the eye (dura mater
transplants, neurosurgical instruments or devices, corneal
transplants), whilst in the other half, injection of pituitary
hormones means that a peripheral route of entry has to be
assumed [9]. Experimental efficiency of prion disease
transmission to animals depends on various factors, such
as the inoculum dose, the species barrier between the spe-
cies of origin of the inoculum and the host, and the route
of administration, among others. Under the same experi-
mental conditions, different routes of administration
show different efficacy of disease transmission, in terms of
length of incubation period and percentage of infected
animals [16,17]. While the most efficient route of trans-
mission is intracerebral administration, other routes, such
as intraperitoneal, intraneural, intraocular, intravenous,
subcutaneous and intramuscular administration, have
been used successfully in bioassays and other experimen-
tal models [18]. Still other routes, such as oral administra-
tion and conjunctival instillation [19], have shown a
lower efficiency of transmission. Accordingly, clinical and
experimental evidence includes several routes of prion
transmission that cannot be easily reduced to a simple tis-
sue classification involving tissues of known infectivity in
CJD and/or expression of PrPC under normal conditions.
This is the case of anterior ophthalmic tissues, skeletal
muscle, peritoneum, and subcutaneous tissue rich in sen-
sitive nerve fibres. These anatomical structures have there-
fore been independently added to our classification as
putative routes of entry, with a lower level of risk com-
pared to the high level represented by the central nervous
system, sensitive ganglia and posterior eye tissues. The fact
that PrPSc has been recently found in 1/4 skeletal muscle
samples of sCJD cases[20] prompted us to classify it as a
tissue for potential entry rather than a route.
A final classification of entry sites for putative surgical
transmission of CJD contains tissues, including all those
showing positive results for sporadic and familial CJD in
the WHO classification [14], with minor additions (tonsilBMC Public Health 2005, 5:9 http://www.biomedcentral.com/1471-2458/5/9
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and thymus), and maintains the three risk levels of the
original classification along with several putative routes of
entry, based on clinical and experimental evidence (see
Table 1).
Discussion
We propose a list intended to be used to generate
attributes of single, well-defined surgical procedures and
criteria for their classification in terms of putative risk
level of transmission. The two main attributes will be: 1)
use of non-disposable surgical instruments; and, 2) expo-
sure during surgery of tissues included in the preceding
list. High- and lower-risk surgical procedures will be
defined by exposure of tissue corresponding to the respec-
tive risk level during surgery. In addition, the lowest risk
level is represented by those surgical procedures where
disposable surgical instruments are not employed or
where no listed tissue or anatomical structure is exposed
to surgical instruments.
A categorisation of surgical procedures based on the above
attributes is inevitably prone to some degree of subjectiv-
ity, something that should be minimised by adequate
methodological assessment. However, this drawback is
more than offset by the possible benefits of identifying
specific surgical procedures that pose a significant risk of
CJD transmission, in terms of increased study power and
control of misclassification of exposure by the removal of
surgical procedures, which are probably irrelevant for CJD
transmission, from gross anatomical classifications of sur-
gery. We are also aware of the fact that whereas the same
surgical instruments are commonly employed in an
homogeneous group of procedures in some countries, as
is the case of Nordic countries, the same instruments may
circulate through a much wider range of procedures and
putative risk levels in other countries. Final risk for disease
transmission in each surgical procedure combines postu-
lated risk related to tissues exposed in that procedure with
the highest risk level of tissues to which instruments have
Table 1: Proposed classification of entry sites for putative surgical transmission of CJD by risk level.
Risk level Tissues Anatomical structures / routes
High Brain
Spinal cord
Retina, optic nerve
Spinal ganglia
Trigeminal ganglia
Pituitary gland
Dura matera
Lower Peripheral nervesb
Spleen
Lymph nodesc
Tonsild
Thymusd
Placenta
Lung
Liver
Kidney
Blood vesselse
Olfactory mucosa
CSF
Skeletal muscle
Anterior ophthalmic 
Peritoneum
Subcutaneous (high density of sensitive nerve terminals)f
Lowest Other Other
aDura mater does not contain pathological PrP in CJD patients and its infectivity has not been tested. It is included among high-infectivity tissues in 
the WHO classification because of evidence of iatrogenic transmission through dura mater grafts.11The same rationale has been applied to its 
inclusion in the present table.
bOnly surgical procedures on peripheral nerves (e.g., amputation, vagotomy, etc.) will be classified according to this tissue.
cSurgical procedures that include this tissue as putative risk are those involving direct manipulation of lymph node chains, e.g., lymph node excision, 
oncological lymphadenectomy, and intra-abdominal procedures with extensive section of lymph node chains, such as cholecystectomy, gastrectomy 
and diverse types of bowel resection.
dAlthough tonsil and thymic tissue have yielded negative results for infectivity and presence of pathological PrP in sporadic CJD tissue (tonsillar 
tissue has not yet been tested for infectivity), they are included in the table in the lower level group, together with the spleen and lymph nodes for 
biological reasons, in order to assess the role of peripheral lymphoid tissue in surgical transmission.
eOnly procedures involving direct surgery on blood vessels will be classified according to this tissue.
fHand and facial subcutaneous tissue will be included under this heading.Publish with BioMed Central    and   every 
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been previously exposed. Accordingly, results should
always be interpreted in the light of a known or assumed
pattern of instrument circulation between surgical proce-
dure groups. Finally, it is worth stressing that the aim of
the approach presented here is exclusively to produce a
useful tool for epidemiological research in CJD transmis-
sion. Under the present state of knowledge, no conse-
quences for the possible adoption of any practical
recommendation concerning surgery or further preventive
measures are to be drawn from this approach.
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